Clinical Trial Update: Pilot Study to Assess the Efficacy of Botulinum Toxin A Treatments on Pain and Disability in Sub-Acute Low Back Pain [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluating botulinum toxin type A injections for reducing pain and disability in sub-acute low back pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: United States Department of Defense | Conditions: Low Back Pain | Phase 4 | Status: TERMINATED